MUNJOVI Trademark

Trademark Overview


On Saturday, October 17, 2020, a trademark application was filed for MUNJOVI with the United States Patent and Trademark Office. The USPTO has given the MUNJOVI trademark a serial number of 90261241. The federal status of this trademark filing is REGISTERED as of Tuesday, January 25, 2022. This trademark is owned by MorphoSys AG. The MUNJOVI trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals and pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; diagnostic preparations for medical purposes; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medica...

Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research, clinical research in the field of antibodies and pharmaceuticals, and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuti...
munjovi

General Information


Serial Number90261241
Word MarkMUNJOVI
Filing DateSaturday, October 17, 2020
Status700 - REGISTERED
Status DateTuesday, January 25, 2022
Registration Number6625339
Registration DateTuesday, January 25, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 9, 2021

Trademark Statements


Goods and ServicesPharmaceuticals and pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; diagnostic preparations for medical purposes; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; Biological preparations for medical purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research, clinical research in the field of antibodies and pharmaceuticals, and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 4, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 4, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameINCYTE HOLDINGS CORPORATION
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressWILMINGTON, DE 19803

Party NameMorphoSys AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPlanegg D-82152
DE

Party NameMorphoSys AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPlanegg D-82152
DE

Party NameMorphoSys AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPlanegg D-82152
DE

Trademark Events


Event DateEvent Description
Wednesday, October 21, 2020NEW APPLICATION ENTERED
Friday, November 27, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, December 4, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 9, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, March 17, 2021ASSIGNED TO EXAMINER
Friday, March 26, 2021NON-FINAL ACTION WRITTEN
Monday, March 1, 2021ASSIGNED TO LIE
Friday, March 26, 2021NON-FINAL ACTION E-MAILED
Friday, March 26, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 28, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 9, 2021PUBLISHED FOR OPPOSITION
Monday, June 17, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 17, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 17, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 17, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 17, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 31, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 25, 2022REGISTERED-PRINCIPAL REGISTER